An Open-label, Single-arm Exploratory Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer
Latest Information Update: 15 Oct 2024
Price :
$35 *
At a glance
- Drugs Alpha-tocopheroloxyacetic acid-Veana-Therapeutics (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 15 Oct 2024 New trial record